The munKNEE.com Pot Stock Index of the 25 pure-play* cannabis stocks that trade for more than US$1/share advanced 3.7% on Friday with 23 (92%) of the constituents advancing. As a result, 3 of the 4 industry categories advanced as well. The details are as follows:

4 constituents advanced by 5% or more, namely:

1. Trulieve (TCNNF) +7.7%
2. Acreage (ACRGF) +6.3%
3. Neptune (NEPT) +6.0%
4. Rubicon (ROMJF) +5.3% (refer to favorable Q2 financial report here)

19 other constituents advanced less than 5%.

1 constituent declined by 5% or more, namely:

• Avicanna (AVCNF) -6.5%

The only other non-gainer was cbdMD (YCBD), which declined 3.9%

The constituents operate in 4 categories based on their primary area of focus in the cannabis industry and the constituents within each category are identified below with how each of the categories did:

1. The Vertically Integrated (i.e. Seed-to-Sale) Category consists of 21 companies that grow, process, and sell cannabis and hemp flower and related products and it advanced 3.7%.
   • the 7 constituents that are Canadian Licensed Producers (LPs)  advanced 3.0%, on average. They are:
     • ACB; APHA; CGC; CRON; OGI; ROMJF and TLRY
   • the 12 constituents that are U.S. Multi-State Operators (MSOs)  advanced 4.4%, on average. They are:
     • ACRGF; AYRSF; CCHWF; CRLBF; CURLF; GTBIF; JUSHF; PLNHF; SHWZ; TRSSF; TCNNF and HRVSF
   • the 2 MSO constituents that are only involved in the seed-to-sale of CBD from hemp advanced 0.3%, on average. They are:
     • CWBHF and YCBD
2. The Extraction Category consists of companies focused on the extraction of cannabis compounds and their infusion into consumer products and it advanced 4.4%, on average.
   • the 2 constituents in this category are NEPT and VLNCF
3. The Consumption Devices Category consists of companies focused on developing and selling personal consumption devices for cannabis consumers such as vape pens and inhalers. Its price advanced 4.7%.
   • the 1 constituent in this category is GNLN
4. The Biotechnology Category consists of pharmaceutical companies marketing new drugs and products utilizing cannabinoids (CBD) and the category declined 6.5%.
   • the 1 constituent in this category is AVCNF

*The 25 pure-play constituents in the munKNEE.com Pot Stock Index (PSI) are just that - pure - deriving 100% of their revenue from the sale of recreational and medicinal cannabis products and consumption devices to reflect the true health of the marijuana industry in the U.S. and Canada. As a result, the PSI excludes the following 12 ancillary companies often included in marijuana ETFs and industry tracking indices, namely: GW Pharmaceuticals (GWPH), Cara (CARA), Corbus (CRBP), Zynerba (ZYNE), XPhyto (XPHYF),  GrowGeneration (GRWG), Scotts Miracle-Gro (SMG), Innovative Industrial Properties (IIPR), New Age Beverages (NBEV), Alcanna (LQSIF), Alkerna  (KERN) and Village Farms (VFF).